• Contact Us
  • Submit RFI/RFP
  • Trust Center
  • Ethics Hotline (report a violation)
  • LIFE SCIENCES
  • HEALTHCARE
  • RESOURCES
    • The Future Prescription
    • Blog
    • Case Studies & Publications
    • Events
    • Press Releases
  • ABOUT
    • Leadership
    • Board of Directors
    • Our Vision and Mission
    • Careers
    • Locations
  • SIGN IN
    • TriNetX LIVE™
    • EVIDEX®
  • Trial Design
  • Datasets & Analytics
  • Non-US Oncology
  • RWE Generation
  • Drug Safety

A Six-Year Approach To Improving Clinical Trial Efficiencies

May 17, 2018 | News

Clinical Leader, May 2, 2018 Learn more

Bulgaria’s Puls Hospital Aiming for Earlier Clinical Trial Involvement with TriNetX

May 15, 2018 | Press Releases

LONDON, 15 May, 2018 — Puls Hospital, the only private multi-profile hospital in the Blagoevgrad region of Bulgaria, has announced it is partnering with TriNetX to expand its participation in clinical trials by getting involved earlier in the process. “We are looking...

TriNetX to Present at ISPOR 2018 on the Use of Real-World Data as an Established Method for Evaluating Safety & Comparative Effectiveness

May 14, 2018 | Events, Press Releases

CAMBRIDGE, MA – May 14, 2018 – TriNetX™, the global health research network, today announced that it willpresent three posters on the use of real-world data from its federated electronic medical record (EMR)-based network as an established methodology for evaluating...

Somerset Partnership Seeks to Increase Patient Participation in Clinical Trials with TriNetX

Apr 25, 2018 | Press Releases

LONDON, April 25, 2018— Somerset Partnership NHS Foundation Trust, which serves a patient population of 650,000 in the south west region of the U.K., is the first integrated mental and community health trust in the NHS to join TriNetX, with the goal of expanding the...

Tufts Medical Center Joins the TriNetX Network for Enhanced Insight into their Clinical Data

Apr 18, 2018 | Press Releases

Cambridge, MA, April 18, 2018 — Tufts Medical Center (Tufts MC), a 415-bed academic medical center located in downtown Boston, has joined the TriNetX Network to enhance its clinical trial process. Tufts MC brings an additional one million patient lives to the global...

Pfizer Joins the TriNetX Global Health Research Network Formed to Improve Clinical Trial Design and Accelerate the Development of New Drugs

Apr 10, 2018 | Press Releases

Cambridge, MA, April 10, 2018 — Pfizer Inc., a world leader in clinical trial innovation, has joined the TriNetX global health research network. As a member, Pfizer will have access to clinical data from TriNetX’s network of healthcare organizations to support...

USC Keck School of Medicine Seeks to Increase Clinical Trial Opportunities by Joining the TriNetX Global Health Research Network

Mar 19, 2018 | Press Releases

Cambridge, MA, March 19, 2018 — The University of Southern California Keck School of Medicine, one of the preeminent research-intensive medical schools in the United States, has joined the TriNetX global health research network to help increase its clinical trial...

Boston Children’s Hospital Accelerates Data-Driven Approach to Clinical Research by Joining the TriNetX Global Health Research Network

Feb 20, 2018 | Press Releases

Cambridge, MA, February 20, 2018 — Boston Children’s Hospital, the top ranked pediatric hospital in the nation according to U.S. News and World Report, has joined the TriNetX global health research network to further its efforts at bringing a more data-driven approach...

JCO™ Clinical Cancer Informatics – “Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations”

Feb 16, 2018 | Published Research

Appearing in the February 2018 issue of JCO™ Clinical Cancer Informatics, this article investigates using a federated network of real-world data to optimize clinical trials operations. Topaloglu U, Palchuk MB JCO Clinical Cancer Informatics. American Society of...

TriNetX Develops Algorithm for Deducing the Chemotherapy Line of Treatment a Patient is Undergoing

Feb 13, 2018 | Press Releases

Unveils Enhanced Real World Data and Analytics for Oncology Clinical Trials Orlando, FL (SCOPE Summit), February 13, 2018 — TriNetX, the global health research network representing nearly 100 million patients, has developed a groundbreaking chemotherapy lines of...
« Older Entries
Next Entries »

SOLUTIONS

Clinical Trial Design & Optimization

Data Sets & Analytics

Non-US Oncology

Insights & Evidence Generation

Drug Safety & Pharmacovigilance

WHO WE SERVE

Life Sciences

Healthcare Organizations

RESOURCES

Explore TriNetX RWD

Conferences

Webinars

Publications

Case Studies

ENTERPRISE

Leadership

Board of Directors

Careers

Locations

EMAIL OPT-IN

Get the latest on product updates, services, events, expert insights, and top industry trends.

Subscribe now

ABOUT TRINETX, LLC

TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

FOLLOW US

LinkedIn
© TriNetX, LLC All Rights Reserved.
Terms of Use
Privacy & Cookies
Do not sell or share my personal information